Clinical trial
The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels
NCT02593201 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 26, 2016
- Completion date
- June 30, 2019
- Enrollment
- 358 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
peritoneal dialysis